Latest news
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial - Dermatology TimesDermatology Times · Mon, 10 Aug 2026 14:00:21 GMTDivesiran Meets Primary Response End Point in Phlebotomy-Dependent Polycythemia Vera - OncLiveOncLive · Mon, 10 Aug 2026 12:41:31 GMTNamilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis - hcplive.comhcplive.com · Fri, 07 Aug 2026 14:06:13 GMTBemnifosbuvir/Ruzasvir Meets Primary Endpoint in Phase 3 HCV Trial - Contagion LiveContagion Live · Mon, 03 Aug 2026 12:06:41 GMTRitlecitinib Meets Co-Primary End Points in Phase 3 Nonsegmental Vitiligo Trials - Dermatology TimesDermatology Times · Thu, 30 Jul 2026 07:00:00 GMT